Drug Shortage Report for PRO-LORAZEPAM
| Report ID | 67702 |
| Drug Identification Number | 00655651 |
| Brand name | PRO-LORAZEPAM TAB 1.0MG |
| Common or Proper name | LORAZEPAM |
| Company Name | PRO DOC LIMITEE |
| Market Status | MARKETED |
| Active Ingredient(s) | LORAZEPAM |
| Strength(s) | 1MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 1000 |
| ATC code | N05BA |
| ATC description | ANXIOLYTICS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2018-11-27 |
| Estimated end date | |
| Actual end date | 2018-11-29 |
| Shortage status | Resolved |
| Updated date | 2018-11-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
| Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2018-11-30 | English | Compare |
| v5 | 2018-11-29 | French | Compare |
| v4 | 2018-11-29 | English | Compare |
| v3 | 2018-11-28 | English | Compare |
| v2 | 2018-11-27 | French | Compare |
| v1 | 2018-11-27 | English | Compare |
Showing 1 to 6 of 6